0 CHECKOUT

France Pharmaceuticals and Healthcare Report Q4 2015

  • ID: 3397287
  • September 2015
  • Region: France
  • 134 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • GlaxoSmithKline
  • Ipsen
  • Merck & Co
  • Novartis
  • Pfizer
  • Sanofi
  • MORE

The French economy's moderate growth acceleration will continue to pose upside risks to our pharmaceuticals and healthcare forecasts over a multi-quarter horizon. However, although gradually recovering, the pharmaceutical market is expected to remain in negative growth territory in 2015 and 2016 before resuming expansion and ultimately picking up by the end of our forecast period. While the pharmaceuticals and healthcare sector long-term growth fundamentals bode favourably to drugmakers operating in the country, the slow pace of reforms to the labour market will ensure minimal competitiveness gains in France's operating environment, which will continue to translate in subdued rates of investment, including in the pharmaceutical sector.

Risk/Reward Index In Q415 we have revised downwards France RRI score to 70.5 from 71.7 in the last quarter, out of a maximum 100 points. France remains ranked as the third most attractive market to pharmaceutical investors out of 15 markets in Western Europe. The downward revision was due to lower drug spending per capita indices. France's score is boosted by the large multi-billion dollar drug market (market expenditure score of 16.0 out of 20), and large pensionable population (pensionable population score of 8.0 out of 8), but dragged down by poor market expansion (sector value growth score of 0.0 out of 12).

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • GlaxoSmithKline
  • Ipsen
  • Merck & Co
  • Novartis
  • Pfizer
  • Sanofi
  • MORE

SWOT

Political

Economic

Operational Risk

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (France 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (France 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (France 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (France 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (France 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (France 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (France 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (France 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (France 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (France 2013-2019)

Key Risks To The Forecast Scenario

Macroeconomic Forecasts

Economic Analysis
Table: GDP Contribution To Growth (France 2012-2020)

Industry Risk Reward Indices

Western Europe Risk/Reward Index - Q4 2015

France Risk/Reward Index

Rewards

Risks

Market Overview

Industry Trends And Developments

Epidemiology

Health System Structure And Financing

Prescription Drugs

Healthcare Financing: Cost Containment Measures

Healthcare Provision

Public Hospitals
Table: Hospital Activity, 2005-2009
Table: Hospital Activity in Short-Stay Units, 2009
Table: Diagnostic & Therapeutic Procedures Performed In Public & Private Hospitals, 2009
Table: Projected Regional Ranking Of Physicians, 2017
Table: Health Status
Table: Healthcare Funding
Table: Healthcare Resources (France 2009-2014)
Table: Healthcare Personnel (France 2009-2014)
Table: Healthcare Activity (France 2009-2014)

Research & Development

Biotechnology

Clinical Trials

Regulatory Development

Intellectual Property Issues

Pricing & Reimbursement
Table: France Reimbursement Categories

Biosimilars

OTC Medicines

Competitive Landscape

Research-Based Industry

Generic Drugmakers

Pharmaceutical Distribution

Pharmaceutical Retail Sector

Company Profile

GlaxoSmithKline

Ipsen

Merck & Co

Novartis

Pfizer

Sanofi

Servier

Demographic Forecast
Table: Population Headline Indicators (France 1990-2025)
Table: Key Population Ratios (France 1990-2025)
Table: Urban/Rural Population & Life Expectancy (France 1990-2025)
Table: Population By Age Group (France 1990-2025)
Table: Population By Age Group % (France 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

GlaxoSmithKline

Ipsen

Merck & Co

Novartis

Pfizer

Sanofi

Servier

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.